Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis
Infective endocarditis (IE) is a rare but increasingly prevalent disease with high morbidity and mortality, requiring antimicrobials and at times surgical intervention. Through the decades of healthcare professionals’ experience with managing IE, certain dogmas and uncertainties have arisen around i...
Main Authors: | Jennifer L. Adema, Aileen Ahiskali, Madiha Fida, Krutika Mediwala Hornback, Ryan W. Stevens, Christina G. Rivera |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/12/5/703 |
Similar Items
-
Correction: Adema et al. Heartbreaking Decisions: The Dogma and Uncertainties of Antimicrobial Therapy in Infective Endocarditis. <i>Pathogens</i> 2023, <i>12</i>, 703
by: Jennifer L. Adema, et al.
Published: (2024-02-01) -
Oral step-down for Staphylococcus aureus bacteraemia: An opportunity for antimicrobial stewardship?
by: Stephen Platts, et al.
Published: (2022-11-01) -
Impact of the COVID-19 Pandemic on the Management of <i>Staphylococcus aureus</i> Bloodstream Infections in a Tertiary Care Hospital
by: Christian W. Böing, et al.
Published: (2023-04-01) -
Enterococcal Endocarditis: Prospective Data from the Iranian Registry of Infective Endocarditis
by: Pardis Moradnejad, et al.
Published: (2022-09-01) -
Evaluation of Anti-Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Prescribing Habits in Patients with a Positive MRSA Nasal Swab in the Absence of Positive Cultures
by: Madeline Pelham, et al.
Published: (2023-05-01)